Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Canagliflozin vs Standard Dual Therapy in T2DM During Ramadan (Can Do)
NCT02694263Phase 4Completed
- Sponsor
- University of Leicester
- Start
- Jul 2016
- Primary completion
- Sep 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of canagliflozin in type 2 diabetes mellitus (T2DM), sponsored by University of Leicester. Started Jul 2016; status: completed.
02
Drugs
canagliflozin
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on NCT02694263.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02694263.